X0508 4 2024-03-22 false 0001828105 Hippo Holdings Inc. HIPO 0001969714 Harry Yuval C/O HIPPO HOLDINGS INC., 150 FOREST AVE PALO ALTO CA 94301 false true false false Chief Revenue Officer false Common Stock 2024-03-22 4 M false 3855.00 8.50 A 150769.00 D Common Stock 2024-03-22 4 M false 3333.00 8.50 A 154102.00 D Common Stock 2024-03-22 4 M false 5998.00 4.00 A 160100.00 D Common Stock 2024-03-22 4 S false 1752.00 17.2505 D 158348.00 D Common Stock 2024-03-22 4 S false 5998.00 17.1919 D 152350.00 D Common Stock 2024-03-22 4 S false 3333.00 17.1968 D 149017.00 D Common Stock 2024-03-22 4 S false 3855.00 17.1793 D 145162.00 D Stock Options (Right to buy) 8.50 2024-03-22 4 M false 3855.00 0.00 D 2029-01-22 Common Stock 3855.00 0.00 D Stock Options (Right to buy) 8.50 2024-03-22 4 M false 3333.00 0.00 D 2029-05-14 Common Stock 3333.00 0.00 D Stock Options (Right to buy) 4.00 2024-03-22 4 M false 5998.00 0.00 D 2028-01-23 Common Stock 5998.00 0.00 D This transaction was executed in multiple trades at prices ranging from $17.25 USD to $17.28 USD; the price reported above reflects the weighted average sale price. This transaction was executed in multiple trades at prices ranging from $17.14 USD to $17.33 USD; the price reported above reflects the weighted average sale price. This transaction was executed in multiple trades at prices ranging from $17.17 USD to $17.24 USD; the price reported above reflects the weighted average sale price. This transaction was executed in multiple trades at prices ranging from $17.12 USD to $17.24 USD; the price reported above reflects the weighted average sale price. Includes 94,719 RSUs. The option, representing the right to purchase common stock of the Issuer, was granted under the 2019 Stock Option and Grant Plan and was fully vested and exercisable as to all underlying shares as of January 23, 2023. The option, representing the right to purchase common stock of the Issuer, was granted under the 2019 Stock Option and Grant Plan and was fully vested and exercisable as to all underlying shares as of May 13, 2023. The option, representing the right to purchase common stock of the Issuer, was granted under the 2019 Stock Option and Grant Plan and was fully vested and exercisable as to all underlying shares as of February 1, 2022. /s /Stewart Ellis, Attorney-in-Fact for Yuval Harry 2024-03-26